THC Therapeutics, Inc. announced earnings results for the second quarter ended January 31, 2021. For the second quarter, the company announced operating loss was USD 327,909 compared to USD 394,947 a year ago. Net loss was USD 359,825 compared to USD 867,039 a year ago. Basic loss per share from continuing operations was USD 0.02 compared to USD 0.07 a year ago. For the half year, operating loss was USD 441,956 compared to USD 567,204 a year ago. Net loss was USD 449,875 compared to USD 1.012 million a year ago. Basic loss per share from continuing operations was USD 0.02 compared to USD 0.08 a year ago.